Zensar has been recognized as a Major Contender in the Everest Group Life Sciences Enterprise Platform Services PEAK Matrix® Assessment 2025.
“The life sciences enterprise platform services market is undergoing rapid transformation, driven by the industry’s push for greater agility, patient-centricity, and stricter regulatory expectations. Enterprises are embracing next-generation enterprise platforms such as SAP, Salesforce, and Oracle — not just as systems of record, but as intelligent enablers of business innovation. As adoption deepens, challenges around complex migrations, compliance, and cross-functional integration persist, prompting a need for domain-rich, cloud-native solutions with strong execution maturity," said Rohit, Practice Director at Everest Group.
“Zensar supports life sciences clients across SAP, Salesforce, and Oracle through a focused set of industry-aligned solutions, including ZenLife, ZenA+, and Cloud RAFT+. Its acquisition of BridgeView Life Sciences has enhanced its ability to deliver Salesforce-based commercial solutions, while its cost-efficient delivery model continues to resonate with mid-market clients. Combined with its flexibility, responsiveness, and strong execution across enterprise platform programs, these attributes have contributed to Zensar’s recognition as a Major Contender in the 2025 Life Sciences Enterprise Platform Services PEAK Matrix® Assessment.”